Archemin

Advice & reporting for the chemical and pharmaceutical industries

News & updates

Multicentre observational trial

posted on September 01st 2009 by Ludwig Everaert
In support of the revision of the reimbursement criteria of a product reimbursed in Class I, we designed and launched a retrospective multicentre observational trial.

10 th Anniversary

posted on June 24th 2009 by Ludwig Everaert
We celebrate our 10-year anniversary !!

Class I reimbursement

posted on November 30th 2008 by Inneke Van de Vijver
Class I reimbursement was granted to Octreoscan in Belgium. Octreoscan imaging agent is a unique molecular imaging agent for the scintigraphic localization of primary and metastatic neuroendocrine tumors bearing somatostatin receptors.

Class I reimbursement

posted on May 19th 2008 by Inneke Van de Vijver
Class I reimbursement was granted to Hexvix (product with a proven phamaco-economical plus value).

Class I reimbursement

posted on April 21st 2007 by Inneke Van de Vijver
DaTSCAN has successfully passed its individual revision of Class I reimbursement.

Pack Insert Readability Testing

posted on January 02nd 2007 by Ludwig Everaert
A 2-year contract has been signed for Pack Insert Readability testing of the entire product range of one of the largest pharmaceutical companies operating in our area. For further information about what we have to offer, have a look at our page Readability testing of Pack Insert Leaflets.

Readability testing for Pack Inserts

posted on January 02nd 2007 by Ludwig Everaert
According to the “Circular 469” letter of the Belgian FA, Pack Inserts submitted or approved before 26 May 2006 also will have to comply within 5 years (national procedure). This means that, by May 2011, all products already authorised in Belgium must be tested.

Saving more than 1 Million euro

posted on October 10th 2006 by Ludwig Everaert
A small start-up business is saved from bankruptcy with our help. If you would like to know how we saved our client more than 1 Million euro in VAT, interests and fines, contact us!

Qualified and experienced professionals

posted on August 15th 2006 by Ludwig Everaert
Out team emphasises the delivery of expertise over volume, which clearly benefits the quality level.

Orphan drugs reimbursement

posted on June 04th 2006 by Ludwig Everaert
Belgian Class I reimbursement is obtained for 2 orphan drugs.

Pages